NWWA
XBI icon

New Wave Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

New Wave Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+1,430
New +$193K 0.06% 190
2026
Q1 		– Sell
-1,992
Closed -$243K – 227
2025
Q4 		$243K Buy
+1,992
New +$228K 0.09% 162

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

New Wave Wealth Advisors's XBI Position: Q2 2026 in Review

New Wave Wealth Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,430 shares worth $226K. The stake represents 0.06% of the portfolio and ranks #190 among its holdings. This is a return to the name: New Wave Wealth Advisors previously reported a position in XBI as recently as Q4 2025.

New Wave Wealth Advisors first reported a position in XBI in Q4 2025 and has held it in 2 quarters since. The position peaked at $243K in Q4 2025. 349 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • New Wave Wealth Advisors held 1,430 shares of State Street SPDR S&P Biotech ETF worth $226K as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new New Wave Wealth Advisors position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.06% of New Wave Wealth Advisors's portfolio in Q2 2026, its #190 holding.
  • New Wave Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 2 quarters since.
  • New Wave Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $243K in Q4 2025.
  • 349 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on New Wave Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.